Circulating inflammatory cytokines

1 paper1 finding

Human trial1

Interventions

1

Nicotinamide riboside

downin humans1

1 study

Nicotinamide riboside decreases circulating inflammatory cytokines in humans.
“NR also depressed levels of circulating inflammatory cytokines.”
Human trial1 g per day21 daysmalesn = 12
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD⁺ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Cell reports13 Aug 2019

More on Nicotinamide riboside

Latest

3 in 12 months

bioRxiv24 Sep

Whole-Blood Transcriptomics Highlights Galectin-1 in Systolic Blood Pressure

Preprint: cohort study of 419 peopleBiomarkers

NeuroImage22 Sep

Association of glymphatic system, neurofluidic dysfunction, and peripheral inflammation in age-related hearing loss

Case-control study in peopleInflammation

Diagnostics27 Aug

Assessment of Sleep, Cognitive Performance, and Circulating Cytokines in Adults with Chronic Rhinosinusitis

Case-control study in peoplePopulations

Cell Reports13 Aug

Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD⁺ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures

Randomised trial in 12 peopleNicotinamide riboside